Walgreens debuts as dog of the Dow

Go back to Walgreens debuts as dog of the Dow

Guggenheim Remains Bullish on Amazon (AMZN) Following PillPack Acquisition

July 2, 2018 7:37 AM EDT

Guggenheim reiterated a Buy rating and $1850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's recent acquisition of PillPack. This drove a 5-10% correction in drug retail shares on the assumption that this would place incremental pressure on pricing and profitability.

Analyst John... More

Walgreens Boosts Alliance (WBA) PT Lowered to $68 at RBC Capital

June 29, 2018 8:02 AM EDT

RBC Capital lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $68.00 (from $88.00) while maintaining an Outperform rating.

Analyst George Hill views the sharp downward move Thursday following Amazon's entry into the pharmacy space as an overreaction.

... More